![Jeffrey B. Nickel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey B. Nickel
Plus aucun poste en cours
82 ans
Health Technology
Profil
Jeffrey B. Nickel, Ph.D., aged 61 years, became Vice President of Business Development and Markeing during June 2004 and served on the Board of Directors from 1997 until June 2004.
Dr. Nickel was the President of Nickel Consulting through which he served as a consultant to companies in the pharmaceutical and biotechnology industries from 1990 until becoming Vice President of BioTime.
Prior to starting his consulting business, Dr. Nickel served in a number of management positions for Syntex Corporation and Merck Company.
Dr. Nickel received his Ph.D.
in Organic Chemistry from
Rutgers University in 1970.
Anciens postes connus de Jeffrey B. Nickel
| Sociétés | Poste | Fin |
|---|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Corporate Officer/Principal | 23/10/2007 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Lineage Cell Therapeutics, Inc.
 Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
